Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Transgenomic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Transgenomic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Transgenomic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Transgenomic Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Transgenomic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Transgenomic Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For US$4 Million 12
Partnerships 14
LifeLabs Enters into Licensing Agreement with Transgenomic 14
University of Melbourne Enters into Licensing Agreement with Transgenomic 15
Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy 16
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 17
Transgenomic Expands Exclusive Licensing Agreement With Dana-Farber Cancer Institute 18
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 19
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 20
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 21
Transgenomic Enters Into Distribution Agreement With ScreenCell 22
Transgenomic Enters Into Distribution Agreement With A. Menarini Diagnostics 23
Transgenomic Expands Licensing Agreement with Exiqon 24
Transgenomic Enters Into Licensing Agreement With Montefiore Medical 25
Equity Offering 26
Transgenomic Raises USD1.2 Million in First Tranche of Private Placement of Shares 26
Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares 28
Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant 29
Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 30
Transgenomic Raises USD7 Million in Private Placement of Shares 32
Transgenomic Completes Private Placement Of Shares For USD8.3 Million 33
Transgenomic Completes Private Placement Of Shares For US$19 Million 34
Debt Offering 35
Transgenomic Raises USD1.2 Million in Private Placement 35
Asset Transactions 36
ADSTEC Acquires Genetic Assays & Platforms Business Unit from Transgenomic 36
Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million 37
Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million 38
Acquisition 39
Transgenomic Acquires Precipio Diagnostics 39
Transgenomic Inc – Key Competitors 40
Transgenomic Inc – Key Employees 41
Transgenomic Inc – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 43
Financial Announcements 43
Aug 12, 2016: Transgenomic Reports Second Quarter 2016 Financial Results 43
May 24, 2016: Transgenomic Reports First Quarter 2016 Financial Results 45
Apr 14, 2016: Transgenomic Reports Full Year 2015 Financial Results 47
Legal and Regulatory 49
Mar 09, 2016: Ground-breaking settlement changes landscape for genetic medicine in Canada 49
Product News 50
Jun 13, 2017: European Patent Office Confirms Grant of New ICE COLD-PCR Patent Exclusively Licensed to Transgenomic 50
Jun 14, 2016: Transgenomic Accelerates Commercialization of ICE COLD-PCR (ICP) amid Plans to Expand Cancer Product Line Ten-Fold 51
Jun 07, 2016: Transgenomic Releases New Data at ASCO 2016 Conference Confirming Concordance of ICE COLD-PCR Liquid and Tissue Biopsies 52
May 16, 2016: Transgenomic Study Data Shows 100% Concordance between ICE COLD-PCR (ICP) Liquid Biopsies and Conventional Tissue Biopsy Results; ICP Also Identifies More Tumor Mutations Than Conventional Methods 53
Mar 29, 2016: Transgenomic to Present Data Confirming Utility of ICE COLD-PCR Liquid Biopsy Technology at American Association for Cancer Research 2016 Annual Meeting 54
03/18/2016: Transgenomic Launches First Commercially Available Assay for Ultra Low Level Detection of EGFR C797S Mutations that Predict Resistance to Third Generation Kinase Therapies for Lung Cancer 55
03/10/2016: Transgenomic Launches New MX-ICP Liquid Biopsy Test for Comprehensive Detection of Colorectal Tumor Mutations 56
03/10/2016: Transgenomic Launches New MX-ICP Liquid Biopsy Test for Comprehensive Detection of Melanoma Tumor Mutations 57
Jan 26, 2016: Transgenomic Highlights Unique Advantages of Multiplexed ICE COLD-PCR at Personalized Medicine World Conference 58
Jan 19, 2016: Transgenomic Launches New MX-ICP Panels for Liquid Biopsy Detection of RAS and PIK3CA Tumor Mutations 59
Other Significant Developments 60
Sep 29, 2016: Transgenomic Adds New Distributors in China and India for its ICEme Kits that Enable Liquid Biopsy Cancer Testing on Existing Platforms 60
Aug 08, 2016: VWR to Distribute Transgenomic’s ICEme Kits That Enable Liquid Biopsy-Based Cancer Research on Existing Platforms 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
Transgenomic Inc, Medical Equipment, Key Facts, 2016 2
Transgenomic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Transgenomic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Transgenomic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Transgenomic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Transgenomic Inc, Deals By Market, 2011 to YTD 2017 9
Transgenomic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For US$4 Million 12
LifeLabs Enters into Licensing Agreement with Transgenomic 14
University of Melbourne Enters into Licensing Agreement with Transgenomic 15
Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy 16
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 17
Transgenomic Expands Exclusive Licensing Agreement With Dana-Farber Cancer Institute 18
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 19
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 20
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 21
Transgenomic Enters Into Distribution Agreement With ScreenCell 22
Transgenomic Enters Into Distribution Agreement With A. Menarini Diagnostics 23
Transgenomic Expands Licensing Agreement with Exiqon 24
Transgenomic Enters Into Licensing Agreement With Montefiore Medical 25
Transgenomic Raises USD1.2 Million in First Tranche of Private Placement of Shares 26
Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares 28
Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant 29
Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 30
Transgenomic Raises USD7 Million in Private Placement of Shares 32
Transgenomic Completes Private Placement Of Shares For USD8.3 Million 33
Transgenomic Completes Private Placement Of Shares For US$19 Million 34
Transgenomic Raises USD1.2 Million in Private Placement 35
ADSTEC Acquires Genetic Assays & Platforms Business Unit from Transgenomic 36
Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million 37
Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million 38
Transgenomic Acquires Precipio Diagnostics 39
Transgenomic Inc, Key Competitors 40
Transgenomic Inc, Key Employees 41
Transgenomic Inc, Other Locations 42
Transgenomic Inc, Subsidiaries 42
